Page 97 - Read Online
P. 97

Page 2 of 12                                                     Liu et al. Hepatoma Res 2020;6:42  I  http://dx.doi.org/10.20517/2394-5079.2020.25

               rs378409 and TM6SF2 rs58542926 improved HCC prediction better than with either variant alone. Incorporating
               new variants and risk factors has the potential to build better algorithms/models to predict onset, early diagnosis
               and treatments for AC-related HCC. However, clinical usefulness of these approaches is yet to be determined.


               Keywords: Alcohol-related cirrhosis, PNPLA3, HSD17B13, TM6SF2, risk prediction




               INTRODUCTION
               Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, with increasing incidence
                        [1]
               worldwide . Despite screening programs in high-risk populations, long-term outcome is poor with a
               5-year survival of 18%, representing the world’s third most lethal cancer. More specifically, the World
                                                                                                  [2]
               Health Organization estimates that more than a million patients will die from liver cancer in 2030 .
               In almost 90% of cases, HCC occurs in the context of chronic liver disease, in particular, on the background
                         [1,3]
               of cirrhosis . The underlying chronic liver disease promoting liver carcinogenesis varies geographically .
                                                                                                        [1]
               In Asia and sub-Saharan Africa, HCC is mostly caused by hepatitis B virus infection, while in the United
               States and Europe the current leading etiologies are hepatitis C virus (HCV) infection and alcohol-related
                                                                               [4]
               cirrhosis (AC) followed by non-alcohol-related fatty liver disease (NAFLD) . However, the advent of new
               direct-acting antiviral agents is expected to control HCV-related HCC in upcoming years, and AC will
                                                                              [1]
               soon become the leading cause of HCC in most high-income countries . Clinical risk factors for HCC
                                                                                                       [5-7]
               occurrence include male gender, older age, severity of cirrhosis, obesity and presence of type 2 diabetes .
                                                                                                     [6]
               Clinical risk models have shown that the individual risk of HCC development is highly variable . In
               addition, case-control and cancer database studies have highlighted the impact of ethnic background and
                                         [8,9]
               a significant familial clustering . For example, individuals of African and Hispanic ancestry are less likely
               to undergo curative therapies . Overall, these observations strongly suggest that inherited genetic factors
                                        [10]
               contribute to hepatocarcinogenesis.

               Here, we review the current literature on risk factors, with a particular focus on genetic risk variants for
               alcohol-related HCC occurrence.

               EPIDEMIOLOGY AND CHARACTERISTICS OF ALCOHOL-RELATED HCC
               Alcohol-related HCC occurs infrequently in patients without pre-existing cirrhosis. Cirrhosis (of any
               etiology) is the single biggest risk factor for HCC development [3,11,12] . The annual incidence of HCC in
                                          [13]
               patients with AC is nearly 3% . The risk of developing AC and HCC parallels the amount of alcohol
               consumed daily and significantly increases above a threshold of 20 and 30 g for females and males,
               respectively [14,15] . Heavy alcohol drinking of more than 80 g per day for longer than 10 years increases the
                                  [16]
               risk of HCC by 5-fold . More specifically, AC accounts for 30% of the global incidence of HCC and HCC-
                                                             [17]
               related deaths, with marked geographical differences . In Europe, HCC occurrence on the background
               of alcohol-related liver disease (ALD) varies from 20% in the south (e.g., Italy or Spain), to 63% in eastern
               countries. In the United States, alcohol accounts for 13% to 23% of HCC cases. Finally, the prevalence of
               alcohol-related HCC reaches 6% in the Middle East and 14% in North Africa [17,18] . The influence of alcohol
               consumption has also been highlighted by the impact of alcohol withdrawal on HCC development. Thus, a
                                                                        [19]
               meta-analysis reported an annual reduction of HCC risk by 6%-7% .
               However, only up to 10%-35% of excessive drinkers develop advanced fibrosis or cirrhosis and its associated
               HCC risk . Interestingly, the role of alcohol consumption seems to be milder or even negligible compared
                       [20]
               to other environmental factors in the setting of HCC occurring in a non-fibrotic liver. For example, a recent
               case-control study observed that after adjustment of smoking habits and metabolic syndrome features,
   92   93   94   95   96   97   98   99   100   101   102